Paracetamol and cytarabine binding competition in high affinity binding sites of transporting protein

Paracetamol (acetaminophen, AA) the most popular analgesic drug is commonly used in the treatment of pain in patients suffering from cancer. In our studies, we evaluated the competition in binding with serum albumin between paracetamol (AA) and cytarabine, antyleukemic drug (araC). The presence of one drug can alter the binding affinity of albumin towards the second one. Such interaction can result in changing of the free fraction of the one of these drugs in blood.Two spectroscopic methods were used to determine high affinity binding sites and the competition of the drugs.Basing on the change of the serum albumin fluorescence in the presence of either of the drugs the quenching (KQ) constants for the araC–BSA and AA–BSA systems were calculated. Analysis of UV difference spectra allowed us to describe the changes in drug–protein complexes (araC–albumin and AA–albumin) induced by the presence of the second drug (AA and araC, respectively). The mechanism of competition between araC and AA has been proposed.